Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties 2023-01-20 18:12
CNN's 'Vital Signs' explores the potential of medical non-invasive therapeutic technology 2023-01-20 15:00
VISTA Eye Specialist to host Eye Health Carnival Nationwide in Malaysia 2023-01-20 08:00
Seragon Announces RESTORIN®, the Most Advanced Anti-Aging Nutraceutical to Date 2023-01-19 23:10
Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata 2023-01-19 23:05
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA 2023-01-19 18:56
Healthcare AI Firm Qritive Raises $7.5M to Expand into New Markets 2023-01-19 08:15
Innovent Announces Inclusion in the China National Reimbursement Drug List (NRDL) of TYVYT in Two New Indications, Olverembatinib for the First Listing, BYVASDA, HALPRYZA and SULINNO in Multiple New Indications 2023-01-18 21:34
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster 2023-01-18 21:00
Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services 2023-01-18 19:00
Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS 2023-01-18 18:03
ASG Superconductors and Siemens Healthineers join forces to deliver 10.5T Ultra High Field MRI Systems for ground-breaking brain research 2023-01-18 18:00
WFH Gene Therapy Registry: now live! 2023-01-18 18:00
Docquity delivers 10% market share growth for Philippine-based pharmaceutical client in just one year 2023-01-18 10:00
Mental health focus makes Boehringer Ingelheim stand out as Top Employer 2023 in Asia Pacific for Third Consecutive Year 2023-01-18 09:00
Boehringer Ingelheim Malaysia Honored As Top Employer For The Fifth Consecutive Year 2023-01-18 09:00
Boehringer Ingelheim Vietnam Honored As Top Employer For The Fourth Consecutive Year 2023-01-18 09:00
Telix Reports Fourth Quarter 2022 Financial Results 2023-01-18 08:50
Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer 2023-01-18 08:00
Everest Medicines Announces Top-line Data from Phase I Study of EVER206 on Healthy Subjects in China 2023-01-18 07:30
1 136 137 138 139 140 534